30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

John Lunger

Insider profile

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 60% 68% 82%
Transactions
26 0% Buy
34 71% Buy
47 69% Buy
John Lunger's trades of Adaptimmune Therapeutics PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-17 2025-01-17 PrS Proposed sale
85,491
84.13
US$1,188,407
85,491 84.13 US$1,188,407
2025-01-17 2025-01-17 S Sale
58,890 -17.5%
168.47
US$2,984,742
58,890 -17.5% 168.47 US$2,984,742
2025-01-15 2025-01-15 PrS Proposed sale
30,767
133.75
US$3,197,045
30,767 133.75 US$3,197,045
2025-01-15 2025-01-15 S Sale
9,803 -41.6%
0.57
US$5,635
9,803 -41.6% 0.57 US$5,635
2025-01-15 2025-01-13 PrS Proposed sale
9,739
0.59
US$5,726
9,739 0.59 US$5,726
2025-01-15 2025-01-13 S Sale
5,471 -41.8%
0.59
US$3,216
5,471 -41.8% 0.59 US$3,216
2025-01-15 2025-01-13 S Sale
4,268 -42.2%
0.59
US$2,509
4,268 -42.2% 0.59 US$2,509
2024-01-17 2024-01-17 S Sale
12,805 -40.2%
0.67
US$8,618
12,805 -40.2% 0.67 US$8,618
2024-01-17 2024-01-17 S Sale
5,309 -40.5%
0.67
US$3,573
5,309 -40.5% 0.67 US$3,573
2024-01-17 2024-01-16 S Sale
4,681 -40.0%
0.79
US$3,698
4,681 -40.0% 0.79 US$3,698
2024-01-12 2024-01-12 S Sale
5,220 -39.9%
0.85
US$4,458
5,220 -39.9% 0.85 US$4,458
2024-01-12 2024-01-11 S Sale
4,009 -39.6%
0.84
US$3,354
4,009 -39.6% 0.84 US$3,354
2023-08-01 2023-08-01 S Sale
3,096 -39.6%
0.91
US$2,804
3,096 -39.6% 0.91 US$2,804
2023-01-17 2023-01-17 S Sale
4,440 -37.9%
1.86
US$8,250
4,440 -37.9% 1.86 US$8,250
2023-01-12 2023-01-12 S Sale
4,973 -38.0%
1.71
US$8,484
4,973 -38.0% 1.71 US$8,484
2023-01-12 2023-01-11 S Sale
3,843 -38.0%
1.75
US$6,713
3,843 -38.0% 1.75 US$6,713
2023-01-04 2023-01-04 S Sale
1,100 -38.9%
1.69
US$1,863
1,100 -38.9% 1.69 US$1,863
2022-08-01 2022-08-01 S Sale
2,983 -38.2%
1.77
US$5,290
2,983 -38.2% 1.77 US$5,290
2022-07-05 2022-07-05 S Sale
1,973 -38.9%
1.68
US$3,311
1,973 -38.9% 1.68 US$3,311
2022-01-18 2022-01-18 S Sale
4,368 -37.3%
3.19
US$13,942
4,368 -37.3% 3.19 US$13,942
2022-01-13 2022-01-12 S Sale
1,076 -38.1%
3.54
US$3,813
1,076 -38.1% 3.54 US$3,813
2022-01-13 2022-01-11 S Sale
3,770 -37.3%
3.56
US$13,409
3,770 -37.3% 3.56 US$13,409
2022-01-05 2022-01-04 S Sale
1,070 -37.9%
4.06
US$4,349
1,070 -37.9% 4.06 US$4,349
2021-01-19 2021-01-19 S Sale
4,358 -37.2%
5.67
US$24,708
4,358 -37.2% 5.67 US$24,708
2021-01-12 2021-01-12 S Sale
1,058 -37.5%
6.15
US$6,509
1,058 -37.5% 6.15 US$6,509
2021-01-05 2021-01-04 S Sale
1,065 -37.7%
5.33
US$5,674
1,065 -37.7% 5.33 US$5,674
2020-08-04 2020-08-03 S Sale
4,823 -37.4%
9.25
US$44,613
4,823 -37.4% 9.25 US$44,613
2020-01-15 2020-01-14 S Sale
1,144 -40.5%
5.13
US$5,874
1,144 -40.5% 5.13 US$5,874
2020-01-07 2020-01-06 S Sale
1,148 -40.6%
1.20
US$1,378
1,148 -40.6% 1.20 US$1,378